[ Price : $8.95]
Federal Register notice: FDA announces the fee rate for using a rare pediatric disease priority review voucher for fiscal year 202...[ Price : $8.95]
Federal Register notice: FDA sets the fee rate for using a material threat medical countermeasure priority review voucher for fisc...[ Price : $8.95]
FDA publishes a guidance on benefit/risk assessment in NDAs and BLAs.[ Price : $8.95]
Sidley says three former FDA attorneys have joined its Global Healthcare and FDA practice.[ Price : $8.95]
University of Chicago researchers say FDA should use a more data-driven approach to postmarket drug surveillance to avoid falsely ...[ Price : $8.95]
FDA clears NeuroWave Systems NeuroSENSE bilateral brain monitor to assess the adequacy of anesthesia and sedation in clinical sett...[ Price : $8.95]
FDA issues a warning about the potential risk of injury associated with the use of Max-Lux Corp.s Safe-T-Lite UV Wand because use...[ Price : $8.95]
FDA approves Mirums Livmarli to treat cholestatic pruritus in patients with Alagille syndrome age one and older.